Literature DB >> 8281667

Does external ultrasound accelerate thrombolysis? Results from a rabbit model.

R Kornowski1, R S Meltzer, A Chernine, Z Vered, A Battler.   

Abstract

BACKGROUND: Prior in vitro and in vivo studies have reported that external ultrasound accelerates thrombolysis at intensities too low to have a direct effect on clot dissolution in the absence of a thrombolytic agent. The present study was undertaken to examine the ultrasound effect on thrombolysis and reocclusion in a rabbit thrombosis model. METHODS AND
RESULTS: Blood clots were produced in a femoral artery segment with endothelial damage and distal stenosis. Recombinant tissue-type plasminogen activator (rTPA) was infused at 30 micrograms.kg-1.min-1 for 60 minutes. Femoral artery flow was measured every 5 minutes for 2 hours. Rabbits were randomized to four groups with continuous wave ultrasound on or off with or without intravenous injection of 17 mg/kg aspirin (+US/-US/+Asp/-Asp). Ultrasound frequency and intensity were 1 MHz and 6.3 W/cm2. In seven of eight and five of five rabbits given rTPA and -US/-Asp or -US/+Asp, respectively, reflow was observed, persisting to the end of the observation period. In five of nine and four of five rabbits given rTPA and +US/-Asp or +US/+Asp, reflow was achieved, but persistent reocclusion was subsequently observed in five of five and two of four of these rabbits, respectively. Overall, femoral artery patency was worse and reocclusion occurred more often when ultrasound was added to rTPA (P = .002 by nonparametric ANOVA). However, initial reflow occurred more rapidly with ultrasound exposure (21 +/- 10 and 33 +/- 6 minutes for the +US/+Asp and +US/-Asp groups, respectively) compared with without ultrasound (46 +/- 13 and 74 +/- 14 minutes for the -US/+Asp and -US/-Asp groups, respectively) (P = .03 by ANOVA).
CONCLUSIONS: Although time to initial reflow was shortened by ultrasound, it was associated with less reperfusion and more reocclusion in this model. A possible explanation for these results is ultrasound-induced platelet activation counterbalancing its thrombolysis-accelerating effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8281667     DOI: 10.1161/01.cir.89.1.339

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 2.  Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 3.  Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 4.  Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

5.  Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.

Authors:  S Atar; H Luo; Y Birnbaum; T Nagai; R J Siegel
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

6.  Nonthermal effects of therapeutic ultrasound: the frequency resonance hypothesis.

Authors:  Lennart D Johns
Journal:  J Athl Train       Date:  2002-07       Impact factor: 2.860

7.  Introduction of a rabbit carotid artery model for sonothrombolysis research.

Authors:  Thilo Hölscher; David J Fisher; Golnaz Ahadi; Arne Voie
Journal:  Transl Stroke Res       Date:  2012-06-22       Impact factor: 6.829

8.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

9.  Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.

Authors:  Shaul Atar; Yoram Neuman; Takashi Miyamoto; Ming Chen; Yochai Birnbaum; Huai Luo; Sergio Kobal; Robert J Siegel
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

10.  Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model.

Authors:  Victor Frenkel; Jay Oberoi; Michael J Stone; Melissa Park; Cheri Deng; Bradford J Wood; Ziv Neeman; McDonald Horne; King C P Li
Journal:  Radiology       Date:  2006-02-21       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.